Elsevier’s “Article of the Future” is now Available for all Cell Press Journals
– Cell Readers can Experience the First Four Issues of 2010 for Free
Elsevier, the leading publisher of scientific, technical and medical
information products and services, today announced that all research articles
in its flagship collection of Cell Press journals will be published online in
the new ‘Article of the Future’ format on http://www.cell.com. Previously
released as a demonstration prototype for two sample articles, the “Article
of the Future” is an ongoing collaboration with the scientific community to
redefine how scientific articles are presented online. Successful ideas from
this project are planned to be rolled-out across Elsevier’s portfolio of
2,000 journals available on ScienceDirect, the world’s largest scientific,
technical and medical database.
“By taking advantage of the functionalities afforded by online
publishing, our new article format provides authors and readers with more
effective and efficient ways to present and access scientific information”
said
and incorporate user feedback in developing improvements to the format with
the continuing goal of helping to advance scientific research.
In celebration of the launch and to encourage user feedback, Article of
the Future articles are accessible for free for Cell Press’ flagship title,
Cell, on http://www.cell.com, for the first four issues of 2010.
The ‘Article of the Future’ reflects a new approach to structuring the
traditional sections of a research article, moving away from the linear
format required by print presentation to an integrated, linked navigation
scheme that allows each reader to create a personalized path through the
article’s content. For example, one of the key features of ‘Article of the
Future’ functionality is a tabbed navigation structure through the
Introduction, Results, Figures and Discussion sections, providing experts
with in-depth coverage of a particular experiment, while allowing more
general readers to absorb the main message without being overwhelmed by
additional details.
Readers will also experience a graphical abstract and a highlights
section on the landing page of each article, complimenting the abstract text
by creating a quickly reviewable visual summary and bullet points. In
addition, articles will offer the article’s text, a figure and a figure
caption at the same time on one screen, with a zooming capability to discover
the finer details of a figure. Selected articles take advantage of integrated
multimedia by featuring PaperFlicks, a video tour of an article’s content.
Elsevier’s Content Innovation Initiative
The functional roll-out of these Article-of-the-Future features at Cell
Press is part of Elsevier’s larger Content Innovation initiative. This
initiative aims at improving the formal scientific communication in a
scalable way, and includes efforts to enhance the presentation of the current
scientific article (like the Article of the Future), but also projects to
better connect this article with the larger body of scientific knowledge on
the web (like the Reflect annotation tool
(http://www.elsevier.com/wps/find/authored_newsitem.cws_home/companynews05_01
358), which was recently piloted on Cell articles).
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser’s URL address field. Remove the
space if one exists.)
“The new capabilities in online publishing allow us to move forward from
a one-size-fits-all approach to online formats tailored to specific subject
domains.” remarked IJsbrand Jan Aalbersberg, Vice President of Content
Innovation for Elsevier Science & Technology Journal Publishing. “Content
Innovation is thus also about observing the life-scientist, the
mathematician, and the chemist and adding relevant domain-specific value to
their workflows. And the reactions on our Article-of-the-Future features and
on the Reflect pilot demonstrate that we are on the right track here.”
About Cell Press
Cell Press (http://www.cell.com/cellpress), an Elsevier company, is
committed to improving scientific communication through the publication of
exciting research and reviews. Each of our titles is viewed as a must-read by
the scientific community it serves. Cell Press primary research journals
include the flagship journal Cell, as well as Neuron, Immunity, Molecular
Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry
& Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell, and, new to
Cell Press, Biophysical Journal, and The American Journal of Human Genetics.
Cell Press also publishes the Trends family of reviews journals, including
Trends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive
Sciences.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (http://www.thelancet.com) and Cell
(http://www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),
Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and
Nursing Consult (http://www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(http://www.scival.com) and MEDai’s Pinpoint Review (http://www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.
A global business headquartered in
(http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher
and information provider, which is jointly owned by Reed Elsevier PLC and
Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).
Anna Hogrebe
Elsevier
+31-20-485-3269
newsroom@elsevier.com
SOURCE Elsevier